| Name | Avacincaptad pegol |
|---|
| Description | Avacincaptad pegol is a C5 complement inhibitor that may reduce inflammation-related retinal pigment epithelium (RPE) damage. Avacincaptad pegol caqn be used for the research of stargardt macular dystrophy (STGD1) and geographic atrophy (GA)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |